Cell C is bleeding money, pushing Blue Label deep into the red | Fin24
 
In partnership with
Loading...

Cell C is bleeding money, pushing Blue Label deep into the red

Sep 19 2019 13:10

Blue Label Telecoms [JSE: BLU] gave a preview of its long-awaited results on Thursday. 

Earlier this week, the JSE threatened to suspend the company’s shares because it has not yet released its results for the year to end-May. The JSE set a final deadline of September 30.

On Thursday, the company warned that it would report a headline loss of up to 314c a share – from a profit of 115c the previous year.

While its core business – including providing airtime, data starter pack and prepaid electricity services – remains profitable, its 45% stake in Cell C took a heavy toll.

Cell C's trading losses and write-offs equalled a 287.65c headline loss per Blue Label’s share. Blue Label also reported losses from GloCell (which took over MTN, Vodacom and Cell C contract subscribers from Altech Autopage when it closed down), the Indian payment solution group Oxigen India as well as some of its other investments.

Excluding these investments, the group core headline earnings amounted to between R885m and R922m, compared to R716m last year.  

The debt-laden Cell C is struggling, with MTN recently writing off R211m in unpaid debt from Cell C. Cell C is cutting costs and implemented a hiring freeze. On top of that, the company is also investigating its employees for irregular business practices.

NEXT ON FIN24X

 
 
 
 

Company Snapshot

#MINIBUDGET2019

Struggling power utility Eskom will take centre stage at this year's mini budget
 

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

What do you think about private healthcare in SA?

Previous results · Suggest a vote

Loading...